L. G. Schmidt
Impact in
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
- Electroconvulsive Therapy Studies
- Bipolar Disorder and Treatment
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Schizophrenia research and treatment 7
- Electroconvulsive Therapy Studies 3
-
- Pharmaceutical studies and practices 3
- Co-authors
- R. Grohmann (8 shared papers)E. R�ther (3 shared papers)Andreas Heinz (2 shared papers)Karl T. Schmidt (1 shared paper)J Patzer (1 shared paper)Martin Bauer (1 shared paper)P. Dufeu (3 shared papers)Barbara C. Wolf (3 shared papers)
- Journals
- Psychopharmacology (2 papers)Neuropsychobiology (1 paper)European Archives of Psychiatry and Clinical Neuroscience (1 paper)European Journal of Clinical Pharmacology (1 paper)Pharmacopsychiatry (1 paper)
- Partner nations
- GermanySloveniaSwitzerland
In The Last Decade
L. G. Schmidt
19 papers receiving 347 citations
Peers
Comparison fields: 5 of 72
- Psychiatry and Mental health 142
- Toxicology 28
- Biological Psychiatry 14
- Geriatrics and Gerontology 16
- Cellular and Molecular Neuroscience 84
Countries citing papers authored by L. G. Schmidt
This map shows the geographic impact of L. G. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. G. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. G. Schmidt more than expected).
Fields of papers citing papers by L. G. Schmidt
This network shows the impact of papers produced by L. G. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. G. Schmidt. The network helps show where L. G. Schmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside L. G. Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 83 | |
| 2 | 2001 | 76 | |
| 3 | 1984 | 34 | |
| 4 | 1996 | 25 | |
| 5 | 1989 | 25 | |
| 6 | 1989 | 23 | |
| 7 | 1990 | 21 | |
| 8 | [Pathobiochemistry and pharmacotherapy of alcohol withdrawal delirium]. | 1991 | 14 |
| 9 | 1984 | 13 | |
| 10 | 2007 | 11 | |
| 11 | 1997 | 9 | |
| 12 | 1996 | 9 | |
| 13 | 2000 | 8 | |
| 14 | 2005 | 7 | |
| 15 | [Biological markers of alcoholism]. | 1990 | 4 |
| 16 | 1985 | 3 | |
| 17 | 1986 | 3 | |
| 18 | 2008 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 1994 | 0 |
About L. G. Schmidt
L. G. Schmidt is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Cellular and Molecular Neuroscience, Cognitive Neuroscience and Toxicology, having authored 20 papers that have together received 370 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (7 papers), Substance Abuse Treatment and Outcomes (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Electroconvulsive Therapy Studies (3 papers), Pharmaceutical studies and practices (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and EEG and Brain-Computer Interfaces (2 papers). The work is most often cited by research in Psychiatry and Mental health (142 citations), Toxicology (28 citations), Biological Psychiatry (14 citations), Geriatrics and Gerontology (16 citations) and Cellular and Molecular Neuroscience (84 citations). L. G. Schmidt has collaborated with scholars based in Germany, Slovenia and Switzerland. Frequent co-authors include R. Grohmann, E. R�ther, Andreas Heinz, Karl T. Schmidt, J Patzer, Martin Bauer, P. Dufeu, Barbara C. Wolf, B. Müller‐Oerlinghausen and Hanfried Helmchen. Their work appears in journals such as Psychopharmacology, Neuropsychobiology, European Archives of Psychiatry and Clinical Neuroscience, European Journal of Clinical Pharmacology and Pharmacopsychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.